EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,237 | -41.3% | 8,290 | -36.1% | 0.00% | – |
| Q2 2023 | $112,874 | +699.7% | 12,974 | +170.2% | 0.00% | – |
| Q1 2023 | $14,115 | +605.8% | 4,801 | +1934.3% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 236 | -53.6% | 0.00% | – |
| Q2 2022 | $4,000 | -96.2% | 509 | -94.1% | 0.00% | – |
| Q1 2022 | $105,000 | -46.2% | 8,669 | -45.5% | 0.00% | – |
| Q4 2021 | $195,000 | -68.3% | 15,901 | -73.0% | 0.00% | – |
| Q3 2021 | $615,000 | +2573.9% | 58,948 | +2182.2% | 0.00% | – |
| Q2 2021 | $23,000 | -8.0% | 2,583 | +5.8% | 0.00% | – |
| Q1 2021 | $25,000 | +66.7% | 2,441 | +2.0% | 0.00% | – |
| Q4 2020 | $15,000 | – | 2,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |